The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Skin Disease Treatment Market Research Report 2025
Synopsis
Skin Disease is a general term for diseases that occur in the skin and skin accessory organs. There are many types of it, and visceral diseases can also be manifested on the skin.
The global Skin Disease Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
There are many causes of skin diseases. For example, skin diseases caused by infectious factors, such as leprosy, scabies, fungal diseases, and skin bacterial infections, are often infectious, which not only affects physical health but also causes panic and social discrimination. With the improvement of living standards and the advancement of science and technology, infectious diseases such as leprosy have been significantly controlled worldwide.
This report aims to provide a comprehensive presentation of the global market for Skin Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Disease Treatment.
Report Scope
The Skin Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Skin Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Skin Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
APEIRON Biologics AG
HanAll BioPharma
GlaxoSmithKline plc.
Allergen, Plc.
Anacor Pharmaceuticals
Celgene
Basilea Pharmaceutica
Cipher Pharmaceuticals
Agenus
Astion Pharma A/S
Bristol-Myers Squibb
Almirall S.A.
Galderma
Segment by Type
Medicated Creams and Ointments
Antibiotics
Vitamins and Steroids
Antihistamines
Laser Therapy
Antifungals
Others
Segment by Application
Dermatology Clinics
Skincare Clinics
Hospitals
Aesthetic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Skin Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Skin Disease is a general term for diseases that occur in the skin and skin accessory organs. There are many types of it, and visceral diseases can also be manifested on the skin.
The global Skin Disease Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
There are many causes of skin diseases. For example, skin diseases caused by infectious factors, such as leprosy, scabies, fungal diseases, and skin bacterial infections, are often infectious, which not only affects physical health but also causes panic and social discrimination. With the improvement of living standards and the advancement of science and technology, infectious diseases such as leprosy have been significantly controlled worldwide.
This report aims to provide a comprehensive presentation of the global market for Skin Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Disease Treatment.
Report Scope
The Skin Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Skin Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Skin Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
APEIRON Biologics AG
HanAll BioPharma
GlaxoSmithKline plc.
Allergen, Plc.
Anacor Pharmaceuticals
Celgene
Basilea Pharmaceutica
Cipher Pharmaceuticals
Agenus
Astion Pharma A/S
Bristol-Myers Squibb
Almirall S.A.
Galderma
Segment by Type
Medicated Creams and Ointments
Antibiotics
Vitamins and Steroids
Antihistamines
Laser Therapy
Antifungals
Others
Segment by Application
Dermatology Clinics
Skincare Clinics
Hospitals
Aesthetic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Skin Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Disease Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medicated Creams and Ointments
1.2.3 Antibiotics
1.2.4 Vitamins and Steroids
1.2.5 Antihistamines
1.2.6 Laser Therapy
1.2.7 Antifungals
1.2.8 Others
1.3 Market by Application
1.3.1 Global Skin Disease Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dermatology Clinics
1.3.3 Skincare Clinics
1.3.4 Hospitals
1.3.5 Aesthetic Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Skin Disease Treatment Market Perspective (2019-2030)
2.2 Skin Disease Treatment Growth Trends by Region
2.2.1 Global Skin Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Skin Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 Skin Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 Skin Disease Treatment Market Dynamics
2.3.1 Skin Disease Treatment Industry Trends
2.3.2 Skin Disease Treatment Market Drivers
2.3.3 Skin Disease Treatment Market Challenges
2.3.4 Skin Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Skin Disease Treatment Players by Revenue
3.1.1 Global Top Skin Disease Treatment Players by Revenue (2019-2024)
3.1.2 Global Skin Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Skin Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Skin Disease Treatment Revenue
3.4 Global Skin Disease Treatment Market Concentration Ratio
3.4.1 Global Skin Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Disease Treatment Revenue in 2023
3.5 Skin Disease Treatment Key Players Head office and Area Served
3.6 Key Players Skin Disease Treatment Product Solution and Service
3.7 Date of Enter into Skin Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Skin Disease Treatment Breakdown Data by Type
4.1 Global Skin Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global Skin Disease Treatment Forecasted Market Size by Type (2025-2030)
5 Skin Disease Treatment Breakdown Data by Application
5.1 Global Skin Disease Treatment Historic Market Size by Application (2019-2024)
5.2 Global Skin Disease Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Skin Disease Treatment Market Size (2019-2030)
6.2 North America Skin Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Skin Disease Treatment Market Size by Country (2019-2024)
6.4 North America Skin Disease Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Skin Disease Treatment Market Size (2019-2030)
7.2 Europe Skin Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Skin Disease Treatment Market Size by Country (2019-2024)
7.4 Europe Skin Disease Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Skin Disease Treatment Market Size (2019-2030)
8.2 Asia-Pacific Skin Disease Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Skin Disease Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Skin Disease Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Skin Disease Treatment Market Size (2019-2030)
9.2 Latin America Skin Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Skin Disease Treatment Market Size by Country (2019-2024)
9.4 Latin America Skin Disease Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Skin Disease Treatment Market Size (2019-2030)
10.2 Middle East & Africa Skin Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Skin Disease Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Skin Disease Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 APEIRON Biologics AG
11.1.1 APEIRON Biologics AG Company Detail
11.1.2 APEIRON Biologics AG Business Overview
11.1.3 APEIRON Biologics AG Skin Disease Treatment Introduction
11.1.4 APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2019-2024)
11.1.5 APEIRON Biologics AG Recent Development
11.2 HanAll BioPharma
11.2.1 HanAll BioPharma Company Detail
11.2.2 HanAll BioPharma Business Overview
11.2.3 HanAll BioPharma Skin Disease Treatment Introduction
11.2.4 HanAll BioPharma Revenue in Skin Disease Treatment Business (2019-2024)
11.2.5 HanAll BioPharma Recent Development
11.3 GlaxoSmithKline plc.
11.3.1 GlaxoSmithKline plc. Company Detail
11.3.2 GlaxoSmithKline plc. Business Overview
11.3.3 GlaxoSmithKline plc. Skin Disease Treatment Introduction
11.3.4 GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2019-2024)
11.3.5 GlaxoSmithKline plc. Recent Development
11.4 Allergen, Plc.
11.4.1 Allergen, Plc. Company Detail
11.4.2 Allergen, Plc. Business Overview
11.4.3 Allergen, Plc. Skin Disease Treatment Introduction
11.4.4 Allergen, Plc. Revenue in Skin Disease Treatment Business (2019-2024)
11.4.5 Allergen, Plc. Recent Development
11.5 Anacor Pharmaceuticals
11.5.1 Anacor Pharmaceuticals Company Detail
11.5.2 Anacor Pharmaceuticals Business Overview
11.5.3 Anacor Pharmaceuticals Skin Disease Treatment Introduction
11.5.4 Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2019-2024)
11.5.5 Anacor Pharmaceuticals Recent Development
11.6 Celgene
11.6.1 Celgene Company Detail
11.6.2 Celgene Business Overview
11.6.3 Celgene Skin Disease Treatment Introduction
11.6.4 Celgene Revenue in Skin Disease Treatment Business (2019-2024)
11.6.5 Celgene Recent Development
11.7 Basilea Pharmaceutica
11.7.1 Basilea Pharmaceutica Company Detail
11.7.2 Basilea Pharmaceutica Business Overview
11.7.3 Basilea Pharmaceutica Skin Disease Treatment Introduction
11.7.4 Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2019-2024)
11.7.5 Basilea Pharmaceutica Recent Development
11.8 Cipher Pharmaceuticals
11.8.1 Cipher Pharmaceuticals Company Detail
11.8.2 Cipher Pharmaceuticals Business Overview
11.8.3 Cipher Pharmaceuticals Skin Disease Treatment Introduction
11.8.4 Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2019-2024)
11.8.5 Cipher Pharmaceuticals Recent Development
11.9 Agenus
11.9.1 Agenus Company Detail
11.9.2 Agenus Business Overview
11.9.3 Agenus Skin Disease Treatment Introduction
11.9.4 Agenus Revenue in Skin Disease Treatment Business (2019-2024)
11.9.5 Agenus Recent Development
11.10 Astion Pharma A/S
11.10.1 Astion Pharma A/S Company Detail
11.10.2 Astion Pharma A/S Business Overview
11.10.3 Astion Pharma A/S Skin Disease Treatment Introduction
11.10.4 Astion Pharma A/S Revenue in Skin Disease Treatment Business (2019-2024)
11.10.5 Astion Pharma A/S Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Detail
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Skin Disease Treatment Introduction
11.11.4 Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2019-2024)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Almirall S.A.
11.12.1 Almirall S.A. Company Detail
11.12.2 Almirall S.A. Business Overview
11.12.3 Almirall S.A. Skin Disease Treatment Introduction
11.12.4 Almirall S.A. Revenue in Skin Disease Treatment Business (2019-2024)
11.12.5 Almirall S.A. Recent Development
11.13 Galderma
11.13.1 Galderma Company Detail
11.13.2 Galderma Business Overview
11.13.3 Galderma Skin Disease Treatment Introduction
11.13.4 Galderma Revenue in Skin Disease Treatment Business (2019-2024)
11.13.5 Galderma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
